Drugs / CY
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00350181 Background | Aug 2006 → Aug 2007 | acute graft versus host disease, leukemia, non-Hodgkin lymphoma | Stanford University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CY | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00350181 ↗ |
| Route | Intravenous | “For subjects aged 18-60 with lymphoma 100 mg/kg, IV For subjects aged with AML, ALL or CML 18-50 60 mg/kg, IV For subjects aged 51-60 with MDS, AML or ALL or patients age 18-60...” NCT00350181 ↗ |